Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNeuroOne Medical Technologies Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
NeuroOne Medical Technologies Corporation Earnings Date And Information
NeuroOne Medical Technologies Corporation last posted its earnings results on Wednesday, February 12th, 2025. The company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.16. The company had revenue of 3.27 M for the quarter and had revenue of 3.45 M for the year. NeuroOne Medical Technologies Corporation has generated $0 earnings per share over the last year ($-0.46 diluted earnings per share) and currently has a price-to-earnings ratio of -4.38. NeuroOne Medical Technologies Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based on prior year's report dates.
NeuroOne Medical Technologies Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/12/2025 | Q1 2025 | -$0.10 | $0.06 | 0.16 | $2.10 M | $3.27 M |
| 12/17/2024 | Q4 2024 | -$0.09 | $0.34 | 0.43 | $1.80 M | $272,284 |
| 08/14/2024 | Q3 2024 | -$0.09 | -$0.10 | -0.01 | $1.50 M | $825,776 |
| 05/14/2024 | Q2 2024 | -$0.10 | -$0.11 | -0.01 | N/A | $1.38 M |
| 02/13/2024 | Q1 2024 | -$0.14 | -$0.14 | 0 | $850,000 | $977,649 |
| 12/15/2023 | Q4 2023 | N/A | -$0.13 | N/A | $800,000 | $741,780 |
| 08/14/2023 | Q3 2023 | -$0.20 | -$0.20 | 0 | $339,500 | $629,906 |
| 05/12/2023 | Q2 2023 | N/A | -$0.21 | N/A | N/A | $466,176 |
| 02/13/2023 | Q1 2023 | -$0.11 | -$0.11 | 0 | N/A | $114,579 |
| 12/21/2022 | Q4 2022 | -$0.11 | -$0.08 | 0.03 | $1.80 M | $68,788 |
| 08/11/2022 | Q3 2022 | -$0.22 | -$0.17 | 0.05 | N/A | $32,049 |
| 05/12/2022 | Q2 2022 | -$0.20 | -$0.19 | 0.01 | N/A | $36,584 |
| 02/14/2022 | Q1 2022 | -$0.18 | -$0.18 | 0 | N/A | $33,748 |
| 12/15/2021 | Q4 2021 | N/A | -$0.22 | N/A | $50,000 | $48,336 |
| 08/13/2021 | Q3 2021 | N/A | -$0.25 | N/A | N/A | $40,096 |
| 05/14/2021 | Q2 2021 | N/A | -$0.21 | N/A | N/A | $18,240 |
| 02/16/2021 | Q1 2021 | N/A | -$0.26 | N/A | N/A | $71,474 |
| 12/08/2020 | Q4 2020 | N/A | -$0.08 | N/A | N/A | $1.93 M |
| 08/13/2020 | Q3 2020 | N/A | -$1.33 | N/A | N/A | $0 |
| 05/14/2020 | Q2 2020 | N/A | -$0.29 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroOne Medical Technologies Corporation Earnings: FAQ's
NeuroOne Medical Technologies Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based offlast year's report dates.
In the previous quarter, NeuroOne Medical Technologies Corporation (:NMTC) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.16.
The conference call for NeuroOne Medical Technologies Corporation's latest earnings report can be listened to online.
The conference call transcript for NeuroOne Medical Technologies Corporation's latest earnings report can be read online.
NeuroOne Medical Technologies Corporation (:NMTC) has a recorded annual revenue of $3.45 M.
NeuroOne Medical Technologies Corporation (:NMTC) has a recorded net income of $-12,318,110.NeuroOne Medical Technologies Corporation has generated $-0.46 earnings per share over the last four quarters.
NeuroOne Medical Technologies Corporation (:NMTC) has a price-to-earnings ratio of -4.38 and price/earnings-to-growth ratio is -0.